Large-scale genetic characterization of Parkinson’s disease in the African and African admixed populations
Brain · 2026
DOI: 10.1093/brain/awaf379 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, 2026. Verfasst von Fulya Akçimen und 59 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA. Hauptthemen laut MEDLINE: Parkinson Disease, Black People, Genetic Predisposition to Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HPC Biowulf cluster, Intramural Research Program, NIH.
Abstract (Originalsprache)
Elucidating the genetic contributions to Parkinson’s disease aetiology across diverse ancestries is a critical priority for the development of targeted therapies in a global context. We conducted the largest sequencing characterization of potentially disease-causing, protein-altering and splicing mutations in 710 cases and 11 827 controls from genetically predicted African or African admixed ancestries. We explored copy number variants (CNVs) and runs of homozygosity in prioritized early onset and familial cases. Our study identified rare GBA1 coding variants to be the most frequent mutations among patients with Parkinson’s disease, with a frequency of 4% in our case cohort. Of the 18 GBA1 variants identified, 10 were previously classified as pathogenic or likely pathogenic, four were novel and four were reported as of uncertain clinical significance. The most common known disease-associated GBA1 variants in the Ashkenazi Jewish and European populations, p.Asn409Ser, p.Leu483Pro, p.Thr408Met and p.Glu365Lys, were not identified among the screened Parkinson’s disease cases of African and African admixed ancestry. Similarly, the European and Asian LRRK2 disease-causing mutational spectrum, including LRRK2 p.Gly2019Ser and p.Gly2385Arg genetic risk factors, did not appear to play a major role in Parkinson’s disease aetiology among West African ancestry populations. However, we found three heterozygous novel missense LRRK2 variants of uncertain significance, with two (p.Glu268Ala and p.Arg1538Cys) displaying higher frequencies in the African ancestry population reference datasets. Structural variant analyses revealed the presence of PRKN CNVs with a frequency of 0.7% in African and African admixed cases, with 66% of CNVs detected being compound heterozygous or homozygous in early-onset cases, providing further insights into the genetic underpinnings in early-onset juvenile Parkinson’s disease in these populations. Short tandem repeat analysis also identified ATXN3 CAG repeat expansions within the pathogenic range (CAGn > 45) in three patients with Parkinson’s disease of African ancestry. Novel genetic variation among screened genes warrants further replication and functional prioritization to unravel their pathogenic potential. Here, we created the most comprehensive genetic catalogue of both known and novel coding and splicing variants potentially linked to Parkinson’s disease aetiology in an underserved population and further conducted global and local ancestry analyses to further explore population-specific effects. Our study has the potential to guide the development of targeted therapies in the emerging era of precision medicine. By expanding genetics research to involve underrepresented populations, we hope that future Parkinson’s disease treatments are not only effective but also inclusive, addressing the needs of diverse ancestral groups.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA.
- Center for Alzheimer's and Related Dementias, National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.
- Department of Biomedical Sciences, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town 7505, South Africa.
- South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town 7505, South Africa.
- Genomic Medicine, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44106, USA.
- DataTecnica LLC, Washington, DC 20037, USA.
ORCID-Profile: Fulya Akçimen, Kathryn Step, Suleyman Can Akerman, Dan Vitale, David Standaert
Förderung
- NIH HPC Biowulf cluster
- Intramural Research Program
- NIH
- NIA NIH HHS
- NIA
- NIH HHS
- HHS
- NINDS NIH HHS
Zitieren
APA
Akçimen, F., Paquette, K., Wild Crea, P., Step, K., Waldo, E., Koretsky, M. J., Saffie-Awad, P., Achoru, C., Taiwo, F., Ozomma, S., Onwuegbuzie, G., Khani, M., Grant, S., Owolabi, L., Okereke, C., Oshinaike, O., Iwuozo, E., Akerman, S. C., Lee, P. S., …, & Louie, N. (2026). Large-scale genetic characterization of Parkinson’s disease in the African and African admixed populations. Brain. https://doi.org/10.1093/brain/awaf379
Vancouver
Akçimen F, Paquette K, Wild Crea P, Step K, Waldo E, Koretsky MJ, et al. Large-scale genetic characterization of Parkinson’s disease in the African and African admixed populations. Brain. 2026. doi:10.1093/brain/awaf379
BibTeX
@article{Akimen2026,
author = {Akçimen, Fulya and Paquette, Kimberly and Wild Crea, Peter and Step, Kathryn and Waldo, Emily and Koretsky, Mathew J and Saffie-Awad, Paula and Achoru, Charles and Taiwo, Funmilola and Ozomma, Simon and Onwuegbuzie, Gerald and Khani, Marzieh and Grant, Spencer and Owolabi, Lukman and Okereke, Chiamaka and Oshinaike, Olajumoke and Iwuozo, Emmanuel and Akerman, Suleyman Can and Lee, Paul Suhwan and Oyakhire, Shyngle and Osemwegie, Nosakhare and Daida, Kensuke and Abubakar, Sani and Olusanya, Adedunni and Isayan, Mariam and Alvarez, Christiane and Traurig, Rami and Ogunmodede, Adebimpe and Samuel, Sarah and Makarious, Mary B and Sa'ad, Fadimatu and Olanigan, Rashidat and Levine, Kristin and Ogbimi, Ewere Marie and Vitale, Dan and Odiase, Francis and Ojini, Francis and Odeniyi, Olanike and Fang, Zih-Hua and Obianozie, Nkechi and Hall, Deborah A and Nwazor, Ernest and Xie, Tao and Nwaokorie, Francesca and Padmanaban, Mahesh and Nwani, Paul and Shamim, Ejaz A and Nnama, Alero and Standaert, David and Komolafe, Morenikeji and Dean, Marissa and Osaigbovo, Godwin and Disbrow, Elizabeth and Ishola, Ismaila and Rawls, Ashley and Imarhiagbe, Frank and Chandra, Shivika and Erameh, Cyril and Hinson, Vanessa and Louie, Naomi},
title = {Large-scale genetic characterization of Parkinson’s disease in the African and African admixed populations},
journal = {Brain},
year = {2026},
doi = {10.1093/brain/awaf379}
}
EUVIMED